The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation

We describe the response of imatinib as lifesaving treatment of chronic myeloid leukemia (CML) relapse in seven patients who underwent allogeneic bone marrow transplantation (alloBMT) at our institution over a period of 4 years. Retrospective analysis of their medical records revealed that a mean ag...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Conchon, Monika, Sanabani, Sabri S., Bendit, Israel, Dinardo, Carla Luana, Dias, Lucia, Chamone, Dalton de Alencar Fischer, Dorlhiac-Llacer, Pedro Enrique, Dulley, Frederico Luiz
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2009
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2809434/
https://ncbi.nlm.nih.gov/pubmed/20107580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/357093
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller